The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine for humans.

The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority. The funding followed another $176 million award for an mRNA-based H5N1 avian influenza vaccine that HHS granted Moderna in July 2024.

Recommended Stories

Moderna requests FDA authorization to give adolescents COVID-19 vaccine

FDA approves Pfizer COVID-19 vaccine

HHS awards Moderna $176 million for mRNA bird flu vaccine